{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:33:42Z","timestamp":1791048822415,"version":"4.1.0"},"reference-count":74,"publisher":"Wiley","issue":"11pt2","license":[{"start":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T00:00:00Z","timestamp":1362441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                      typing strategies in several\n                      <jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>\n                      uropean countries protect carriers of\n                      <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                      category\n                      <jats:styled-content style=\"fixed-case\">VI<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">DVI<\/jats:styled-content>\n                      ) from anti\u2010\n                      <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                      immunization but not carriers of other partial\n                      <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                      . Besides\n                      <jats:styled-content style=\"fixed-case\">DVI<\/jats:styled-content>\n                      , one of the clinically most important partial\n                      <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                      is\n                      <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                      category\n                      <jats:styled-content style=\"fixed-case\">IV<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">DIV<\/jats:styled-content>\n                      ). A detailed description and direct comparison of the different\n                      <jats:styled-content style=\"fixed-case\">DIV<\/jats:styled-content>\n                      types was missing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Design and Methods<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>RHD<\/jats:italic>\n                      <\/jats:styled-content>\n                      nucleotide sequences were determined from genomic\n                      <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content>\n                      .\n                      <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                      epitope patterns were established with commercial monoclonal anti\u2010\n                      <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                      panels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">DIV<\/jats:styled-content>\n                      comprises several variants of the\n                      <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                      antigen with distinct serology, molecular structures, evolutionary origins, and ethnic prevalences. The\n                      <jats:styled-content style=\"fixed-case\">DIV<\/jats:styled-content>\n                      phenotype is determined by 350\n                      <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>\n                      shared by all, but not limited to,\n                      <jats:styled-content style=\"fixed-case\">DIV<\/jats:styled-content>\n                      variants which are further divided into\n                      <jats:styled-content style=\"fixed-case\">DIVa<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">DIVb<\/jats:styled-content>\n                      . The\n                      <jats:styled-content style=\"fixed-case\">DIVa<\/jats:styled-content>\n                      phenotype is expressed by\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>DIV Type 1.0<\/jats:italic>\n                      <\/jats:styled-content>\n                      harboring 350\n                      <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>\n                      and the dispersed amino acids 62\n                      <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>\n                      , 137\n                      <jats:styled-content style=\"fixed-case\">V<\/jats:styled-content>\n                      , and 152\n                      <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\n                      . The\n                      <jats:styled-content style=\"fixed-case\">DIVb<\/jats:styled-content>\n                      phenotype is expressed by\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>DIV Type 3<\/jats:italic>\n                      <\/jats:styled-content>\n                      to\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>Type 5<\/jats:italic>\n                      <\/jats:styled-content>\n                      representing\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>RHD\u2010CE\u2010D<\/jats:italic>\n                      <\/jats:styled-content>\n                      hybrids. Four of the six postulated\n                      <jats:styled-content style=\"fixed-case\">DIV<\/jats:styled-content>\n                      variants were encountered among 23\n                      <jats:styled-content style=\"fixed-case\">DIV<\/jats:styled-content>\n                      samples analyzed. Of 12\n                      <jats:styled-content style=\"fixed-case\">DIV<\/jats:styled-content>\n                      carriers with anti\u2010\n                      <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                      , 10 were female and seven likely immunized by pregnancy. Two\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>DIV<\/jats:italic>\n                      <\/jats:styled-content>\n                      \u2010related alleles are newly described:\n                      <jats:styled-content style=\"fixed-case\">DWN<\/jats:styled-content>\n                      , which differs from\n                      <jats:styled-content style=\"fixed-case\">DIV<\/jats:styled-content>\n                      Type 4 by 350\n                      <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                      and epitope pattern.\n                      <jats:styled-content style=\"fixed-case\">DNT<\/jats:styled-content>\n                      carries 152\n                      <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\n                      , known to cause a large\n                      <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                      antigen density.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>DIV<\/jats:italic>\n                      <\/jats:styled-content>\n                      alleles arose from at least two independent evolutionary events.\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>DIV Type 1.0<\/jats:italic>\n                      <\/jats:styled-content>\n                      with\n                      <jats:styled-content style=\"fixed-case\">DIVa<\/jats:styled-content>\n                      phenotype belongs to the oldest extant human\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>RHD<\/jats:italic>\n                      <\/jats:styled-content>\n                      alleles.\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>DIV Type 2<\/jats:italic>\n                      <\/jats:styled-content>\n                      to\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>Type 5<\/jats:italic>\n                      <\/jats:styled-content>\n                      with\n                      <jats:styled-content style=\"fixed-case\">DIVb<\/jats:styled-content>\n                      phenotype arose from more recent gene conversions. Anti\u2010\n                      <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                      immunization, especially dreaded in pregnancies, will be avoided not only in carriers of\n                      <jats:styled-content style=\"fixed-case\">DVI<\/jats:styled-content>\n                      but also in carriers of other\n                      <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                      variants like\n                      <jats:styled-content style=\"fixed-case\">DIV<\/jats:styled-content>\n                      , if our proposed\n                      <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                      typing strategy is adopted.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/trf.12145","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T00:05:44Z","timestamp":1362528344000},"page":"2960-2973","source":"Crossref","is-referenced-by-count":36,"title":["<scp>D<\/scp>\n                    category\n                    <scp>IV<\/scp>\n                    : a group of clinically relevant and phylogenetically diverse partial\n                    <scp>D<\/scp>"],"prefix":"10.1111","volume":"53","author":[{"given":"Inge","family":"von Zabern","sequence":"first","affiliation":[{"name":"Department of Transfusion Medicine University Hospital  Ulm Germany"},{"name":"Institute for Clinical Transfusion Medicine and Immunogenetics  Ulm Germany"},{"name":"DRK (German Red Cross) Blood Donor Service Baden\u2010W\u00fcrttemberg\u2013Hessen, Institute  Ulm Germany"},{"name":"DRK Blood Donor Service NSTOB, Institute  Springe Germany"},{"name":"Scientific Support Services LifeShare Blood Centers  Shreveport Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz F.","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine University Hospital  Ulm Germany"},{"name":"Institute for Clinical Transfusion Medicine and Immunogenetics  Ulm Germany"},{"name":"DRK (German Red Cross) Blood Donor Service Baden\u2010W\u00fcrttemberg\u2013Hessen, Institute  Ulm Germany"},{"name":"DRK Blood Donor Service NSTOB, Institute  Springe Germany"},{"name":"Scientific Support Services LifeShare Blood Centers  Shreveport Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joann M.","family":"Moulds","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine University Hospital  Ulm Germany"},{"name":"Institute for Clinical Transfusion Medicine and Immunogenetics  Ulm Germany"},{"name":"DRK (German Red Cross) Blood Donor Service Baden\u2010W\u00fcrttemberg\u2013Hessen, Institute  Ulm Germany"},{"name":"DRK Blood Donor Service NSTOB, Institute  Springe Germany"},{"name":"Scientific Support Services LifeShare Blood Centers  Shreveport Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Moulds","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine University Hospital  Ulm Germany"},{"name":"Institute for Clinical Transfusion Medicine and Immunogenetics  Ulm Germany"},{"name":"DRK (German Red Cross) Blood Donor Service Baden\u2010W\u00fcrttemberg\u2013Hessen, Institute  Ulm Germany"},{"name":"DRK Blood Donor Service NSTOB, Institute  Springe Germany"},{"name":"Scientific Support Services LifeShare Blood Centers  Shreveport Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willy A.","family":"Flegel","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine University Hospital  Ulm Germany"},{"name":"Institute for Clinical Transfusion Medicine and Immunogenetics  Ulm Germany"},{"name":"DRK (German Red Cross) Blood Donor Service Baden\u2010W\u00fcrttemberg\u2013Hessen, Institute  Ulm Germany"},{"name":"DRK Blood Donor Service NSTOB, Institute  Springe Germany"},{"name":"Scientific Support Services LifeShare Blood Centers  Shreveport Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,3,5]]},"reference":[{"key":"e_1_2_9_2_1","first-page":"895","article-title":"Presence of anti\u2010D antibody in the serum of a Du patient","volume":"41","author":"Argall CI","year":"1953","journal-title":"J Lab Clin Med"},{"key":"e_1_2_9_3_1","volume-title":"The human blood groups","author":"Salmon C","year":"1984"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.1996.tb05625.x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V14.5.522.522"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.110.4.495"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-51-4-740"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/32.6.499"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.1962.tb00230.x"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1959.03000240034008"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1962.tb03223.x"},{"key":"e_1_2_9_12_1","first-page":"476","article-title":"Further observations on subdivisions of the Rh antigen D.","volume":"23","author":"Tippett P","year":"1977","journal-title":"\u00c4rztl Lab"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1996.tb01309.x"},{"key":"e_1_2_9_14_1","first-page":"560","article-title":"TAR+ individuals with anti\u2010D, a new category DVII","volume":"26","author":"Lomas C","year":"1986","journal-title":"Transfusion"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470987018"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.1993.tb00106.x"},{"key":"e_1_2_9_17_1","volume-title":"The RhesusBase, 1998\u20102012","author":"Wagner FF","year":"1998"},{"key":"e_1_2_9_18_1","first-page":"10s","article-title":"The frequency of RHD protein variants in Caucasians","volume":"3","author":"Flegel WA","year":"1996","journal-title":"Transfus Clin Biol"},{"key":"e_1_2_9_19_1","first-page":"285","article-title":"Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinically relevant high\u2010frequency antigens in South\u2010Western Germany","volume":"22","author":"Wagner FF","year":"1995","journal-title":"Infusionsther Transfusionsmed"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.6.2157"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40040428.x"},{"key":"e_1_2_9_22_1","volume-title":"The Rhesus Immunization Surveillance, 1998\u20102009","author":"Flegel WA","year":"1998"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/14767050412331312260"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.06.008"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.632710.x"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830490115"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1246-7820(01)00211-7"},{"key":"e_1_2_9_28_1","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1182\/blood.V87.11.4853.bloodjournal87114853","article-title":"Molecular basis of the altered antigenic expression of RhD in weak D (Du) and RhC\/e in RN phenotypes","volume":"87","author":"Rouillac C","year":"1996","journal-title":"Blood"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0320"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02102.x"},{"key":"e_1_2_9_31_1","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood.V85.10.2937.bloodjournal85102937","article-title":"Transcript analysis of D category phenotypes predicts hybrid Rh D\u2010CE\u2010D proteins associated with alteration of D epitopes","volume":"85","author":"Rouillac C","year":"1995","journal-title":"Blood"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.1.385"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.8.2699"},{"issue":"1","key":"e_1_2_9_34_1","first-page":"63S","article-title":"Characterization of D category IV type IV, DFW, and DNB","volume":"38","author":"Wagner FF","year":"1998","journal-title":"Transfusion"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00580.x"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2000.7820122.x"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.01046.x"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1246-7820(96)80039-5"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1246-7820(01)00213-0"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00495.x"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00181.x"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2156-2-10"},{"issue":"3","key":"e_1_2_9_43_1","first-page":"159A","article-title":"A new RHce allele, RHCE*ceTI, is associated with C typing discrepancies and is linked to RHD*DVIa","volume":"47","author":"Vege S","year":"2007","journal-title":"Transfusion"},{"key":"e_1_2_9_44_1","first-page":"151","volume-title":"Proceedings of the second international workshop and symposium on monoclonal antibodies against human red blood cells and related antigens","author":"Flegel WA","year":"1990"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1246-7820(96)80040-1"},{"key":"e_1_2_9_46_1","first-page":"33s","article-title":"RHD category VII is caused by a single molecular event [abstract]","volume":"3","author":"Flegel WA","year":"1996","journal-title":"Transfus Clin Biol"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1246-7820(96)80049-8"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1997.371098016439.x"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41010045.x"},{"issue":"3","key":"e_1_2_9_50_1","first-page":"158A","article-title":"DIIIa and DIII type 5 partial D phenotypes are encoded by the same RHD variant allele","volume":"47","author":"Westhoff CM","year":"2007","journal-title":"Transfusion"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02573.x"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199707)55:3<139::AID-AJH4>3.0.CO;2-T"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2010.01462.x"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03350.x"},{"key":"e_1_2_9_55_1","volume-title":"The blood group antigen facts book","author":"Reid ME","year":"2003"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.2.375"},{"issue":"3","key":"e_1_2_9_57_1","first-page":"34A","article-title":"DIVa and DIVa\u20102 are encoded by the same RHD allele","volume":"52","author":"Reid ME","year":"2012","journal-title":"Transfusion"},{"issue":"3","key":"e_1_2_9_58_1","first-page":"119A","article-title":"Clinical relevance of D category IV comprising phylogenetically heterogeneous alleles","volume":"49","author":"Zabern I","year":"2009","journal-title":"Transfusion"},{"issue":"3","key":"e_1_2_9_59_1","first-page":"166A","article-title":"An RHD*455C allele encodes a partial D phenotype associated with production of allo anti\u2010D","volume":"52","author":"Fong C","year":"2012","journal-title":"Transfusion"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0742"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2003.03318.x"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-2977(69)80066-0"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1246-7820(96)80070-X"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1246-7820(96)80051-6"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2011.01519.x"},{"issue":"1","key":"e_1_2_9_66_1","first-page":"52","article-title":"Immune alloanti\u2010D in a patient with a novel RHD mutation","volume":"15","author":"Bruce DG","year":"2005","journal-title":"Transfus Med"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02161.x"},{"key":"e_1_2_9_68_1","first-page":"10","article-title":"RHCE*ceTI encodes partial c and partial e and is often in cis to RHD*DIVa","volume":"13","author":"Westhoff CM","year":"2012","journal-title":"Transfusion"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00902.x"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.02005.x"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01305.x"},{"key":"e_1_2_9_72_1","first-page":"172","article-title":"\u00dcberlegungen zum Vorgehen bei der Bestimmung der D\u2010Eigenschaft","volume":"23","author":"Endres W","year":"1996","journal-title":"Infusionsther Transfusionsmed"},{"key":"e_1_2_9_73_1","first-page":"1","article-title":"The challenge and paradox in serology RhD typing for blood donors and patients","author":"Hyland CA","year":"2013","journal-title":"Blood Transfus"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01506.x"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00586.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.12145","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.12145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:16:46Z","timestamp":1694629006000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.12145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,5]]},"references-count":74,"journal-issue":{"issue":"11pt2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1111\/trf.12145"],"URL":"https:\/\/doi.org\/10.1111\/trf.12145","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,5]]}}}